NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Anti-citrullinated SR-A Peptide (Anti-csp) Antibody as a Biomarker in Rheumatoid Arthritis (RA).

Not Yet RecruitingN/A

Sponsor: Walaa sharif Eid Ahmed

Conditions: Rheumatoid Arthritis (RA)

1. To measure serum level of anticitrullinated SR-A peptide antibody (anti-CSP) in RA patients compared to healthy controls . 2. To assess the diagnostic performance of anti-CSP for RA specifically seronegative RA patients. 3. To evaluate correlation of serum anti-CSP level with disease activity and functional disability scores in RA patients.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

Adults (≥18 years old)

Exclusion Criteria:

Patients with other autoimmune or connective tissue diseases (e.g., SLE, SS) .

* Patients with chronic infections or malignancies .
* Patients less than18 years old .